Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boyd Consultants, widely known as Boyds, is a specialist consultancy providing strategic and operational support to the pharmaceutical and biotechnology industries. Founded in 2005 by Professor Alan Boyd, the firm focuses on the development of innovative medicinal products, with a particular emphasis on advanced therapy medicinal products (ATMPs), cell and gene therapies, and orphan drugs. Their comprehensive service offering includes regulatory affairs, medical monitoring, clinical development, and program management. Boyds operates from multiple locations across the UK, Ireland, and the USA, assisting clients in navigating the complex global regulatory landscape. The consultancy is recognized for its deep expertise in helping small to mid-sized biotech companies transition from early-stage research to clinical trials and market approval. By providing tailored expert advice, Boyds helps bridge the gap between scientific innovation and commercial reality for life science organizations worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boyd Consultants.